US Stock MarketDetailed Quotes

GTHP GUIDED THERAPEUTICS INC

Watchlist
  • 0.150000
  • -0.024800-14.19%
15min DelayClose Oct 18 16:00 ET
8.98MMarket Cap-3750P/E (TTM)

GUIDED THERAPEUTICS INC Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
-72.73%6K
653.85%98K
32K
0
780.00%44K
340.00%22K
-83.95%13K
0
-84.21%3K
Operating revenue
--0
-72.73%6K
653.85%98K
--32K
--0
780.00%44K
340.00%22K
-83.95%13K
--0
-84.21%3K
Cost of revenue
0
-77.78%2K
-23.46%62K
-79.75%16K
4K
3,200.00%33K
800.00%9K
32.79%81K
315.79%79K
0
Gross profit
0
-69.23%4K
152.94%36K
120.25%16K
-233.33%-4K
175.00%11K
225.00%13K
-440.00%-68K
-292.68%-79K
113.04%3K
Operating expense
-56.79%655K
-57.59%363K
6.98%3.49M
-42.35%501K
-49.55%619K
110.26%1.52M
91.50%856K
37.07%3.27M
82.56%869K
164.44%1.23M
Selling and administrative expenses
-70.14%433K
-63.60%309K
2.42%3.27M
-50.00%415K
-54.88%550K
103.65%1.45M
99.30%849K
37.83%3.19M
80.83%830K
172.10%1.22M
-Selling and marketing expense
13.11%69K
0.00%73K
48.07%268K
25.00%65K
32.69%69K
64.86%61K
82.50%73K
28.37%181K
52.94%52K
26.83%52K
-General and administrative expense
-73.79%364K
-69.59%236K
-0.33%3M
-55.01%350K
-58.78%481K
105.78%1.39M
101.04%776K
38.44%3.01M
83.06%778K
186.73%1.17M
Research and development costs
236.36%222K
671.43%54K
196.10%228K
120.51%86K
762.50%69K
633.33%66K
-66.67%7K
11.59%77K
129.41%39K
-50.00%8K
Operating profit
56.48%-655K
57.41%-359K
-3.72%-3.46M
48.84%-485K
49.10%-623K
-109.90%-1.51M
-90.29%-843K
-41.11%-3.33M
-117.93%-948K
-151.33%-1.22M
Net non-operating interest income expense
-8.70%-75K
7.58%-61K
53.26%-272K
5.71%-66K
54.19%-71K
73.05%-69K
34.65%-66K
49.39%-582K
30.00%-70K
73.91%-155K
Non-operating interest income
--0
--3K
--6K
----
----
--0
--0
--0
----
----
Non-operating interest expense
8.70%75K
-3.03%64K
-52.23%278K
2.86%72K
-54.19%71K
-73.05%69K
-34.65%66K
-49.39%582K
-30.00%70K
-73.91%155K
Other net income (expense)
23.53%21K
-55.00%18K
156.34%240K
120.91%165K
-93.86%17K
-63.83%17K
8.11%40K
-129.54%-426K
-967.03%-789K
-75.89%277K
Gain on sale of security
---7K
----
-81.48%5K
--0
----
----
183.33%5K
-92.44%27K
800.00%14K
600.00%5K
Special income (charges)
-5.88%16K
-51.43%17K
141.79%196K
115.60%127K
-93.70%17K
-50.00%17K
-14.63%35K
-181.14%-469K
---814K
-64.61%270K
-Less:Other special charges
5.88%-16K
51.43%-17K
-141.79%-196K
-115.60%-127K
93.70%-17K
50.00%-17K
14.63%-35K
181.14%469K
--814K
64.61%-270K
Other non- operating income (expenses)
--12K
--1K
143.75%39K
245.45%38K
----
----
----
-96.84%16K
-88.17%11K
-99.48%2K
Income before tax
54.46%-709K
53.74%-402K
19.63%-3.49M
78.64%-386K
38.57%-677K
-68.14%-1.56M
-71.40%-869K
-109.71%-4.34M
-306.98%-1.81M
-1,720.59%-1.1M
Income tax
0
0
0
0
0
0
0
0
0
0
Net income
54.46%-709K
53.74%-402K
19.63%-3.49M
78.64%-386K
38.57%-677K
-68.14%-1.56M
-71.40%-869K
-109.71%-4.34M
-306.98%-1.81M
-1,720.59%-1.1M
Net income continuous Operations
54.46%-709K
53.74%-402K
19.63%-3.49M
78.64%-386K
38.57%-677K
-68.14%-1.56M
-71.40%-869K
-109.71%-4.34M
-306.98%-1.81M
-1,720.59%-1.1M
Minority interest income
Net income attributable to the parent company
54.46%-709K
53.74%-402K
19.63%-3.49M
78.64%-386K
38.57%-677K
-68.14%-1.56M
-71.40%-869K
-109.71%-4.34M
-306.98%-1.81M
-1,720.59%-1.1M
Preferred stock dividends
4.26%49K
11.43%39K
-72.90%171K
-2.00%49K
183.33%40K
-41.98%47K
-93.61%35K
74.79%631K
-23.08%50K
-140.34%-48K
Other preferred stock dividends
0
0
99K
34K
0
0
65K
0
0
0
Net income attributable to common stockholders
52.74%-758K
54.49%-441K
24.40%-3.76M
74.74%-469K
31.97%-717K
-59.29%-1.6M
8.15%-969K
-104.52%-4.97M
-264.83%-1.86M
-1,966.67%-1.05M
Basic earnings per share
66.67%-0.01
50.00%-0.01
53.33%-0.07
0
66.67%-0.01
25.00%-0.03
60.00%-0.02
16.67%-0.15
0.00%-0.04
-689.27%-0.03
Diluted earnings per share
66.67%-0.01
50.00%-0.01
53.33%-0.07
0
66.67%-0.01
25.00%-0.03
60.00%-0.02
16.67%-0.15
0.00%-0.04
-689.27%-0.03
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0-72.73%6K653.85%98K32K0780.00%44K340.00%22K-83.95%13K0-84.21%3K
Operating revenue --0-72.73%6K653.85%98K--32K--0780.00%44K340.00%22K-83.95%13K--0-84.21%3K
Cost of revenue 0-77.78%2K-23.46%62K-79.75%16K4K3,200.00%33K800.00%9K32.79%81K315.79%79K0
Gross profit 0-69.23%4K152.94%36K120.25%16K-233.33%-4K175.00%11K225.00%13K-440.00%-68K-292.68%-79K113.04%3K
Operating expense -56.79%655K-57.59%363K6.98%3.49M-42.35%501K-49.55%619K110.26%1.52M91.50%856K37.07%3.27M82.56%869K164.44%1.23M
Selling and administrative expenses -70.14%433K-63.60%309K2.42%3.27M-50.00%415K-54.88%550K103.65%1.45M99.30%849K37.83%3.19M80.83%830K172.10%1.22M
-Selling and marketing expense 13.11%69K0.00%73K48.07%268K25.00%65K32.69%69K64.86%61K82.50%73K28.37%181K52.94%52K26.83%52K
-General and administrative expense -73.79%364K-69.59%236K-0.33%3M-55.01%350K-58.78%481K105.78%1.39M101.04%776K38.44%3.01M83.06%778K186.73%1.17M
Research and development costs 236.36%222K671.43%54K196.10%228K120.51%86K762.50%69K633.33%66K-66.67%7K11.59%77K129.41%39K-50.00%8K
Operating profit 56.48%-655K57.41%-359K-3.72%-3.46M48.84%-485K49.10%-623K-109.90%-1.51M-90.29%-843K-41.11%-3.33M-117.93%-948K-151.33%-1.22M
Net non-operating interest income expense -8.70%-75K7.58%-61K53.26%-272K5.71%-66K54.19%-71K73.05%-69K34.65%-66K49.39%-582K30.00%-70K73.91%-155K
Non-operating interest income --0--3K--6K----------0--0--0--------
Non-operating interest expense 8.70%75K-3.03%64K-52.23%278K2.86%72K-54.19%71K-73.05%69K-34.65%66K-49.39%582K-30.00%70K-73.91%155K
Other net income (expense) 23.53%21K-55.00%18K156.34%240K120.91%165K-93.86%17K-63.83%17K8.11%40K-129.54%-426K-967.03%-789K-75.89%277K
Gain on sale of security ---7K-----81.48%5K--0--------183.33%5K-92.44%27K800.00%14K600.00%5K
Special income (charges) -5.88%16K-51.43%17K141.79%196K115.60%127K-93.70%17K-50.00%17K-14.63%35K-181.14%-469K---814K-64.61%270K
-Less:Other special charges 5.88%-16K51.43%-17K-141.79%-196K-115.60%-127K93.70%-17K50.00%-17K14.63%-35K181.14%469K--814K64.61%-270K
Other non- operating income (expenses) --12K--1K143.75%39K245.45%38K-------------96.84%16K-88.17%11K-99.48%2K
Income before tax 54.46%-709K53.74%-402K19.63%-3.49M78.64%-386K38.57%-677K-68.14%-1.56M-71.40%-869K-109.71%-4.34M-306.98%-1.81M-1,720.59%-1.1M
Income tax 0000000000
Net income 54.46%-709K53.74%-402K19.63%-3.49M78.64%-386K38.57%-677K-68.14%-1.56M-71.40%-869K-109.71%-4.34M-306.98%-1.81M-1,720.59%-1.1M
Net income continuous Operations 54.46%-709K53.74%-402K19.63%-3.49M78.64%-386K38.57%-677K-68.14%-1.56M-71.40%-869K-109.71%-4.34M-306.98%-1.81M-1,720.59%-1.1M
Minority interest income
Net income attributable to the parent company 54.46%-709K53.74%-402K19.63%-3.49M78.64%-386K38.57%-677K-68.14%-1.56M-71.40%-869K-109.71%-4.34M-306.98%-1.81M-1,720.59%-1.1M
Preferred stock dividends 4.26%49K11.43%39K-72.90%171K-2.00%49K183.33%40K-41.98%47K-93.61%35K74.79%631K-23.08%50K-140.34%-48K
Other preferred stock dividends 0099K34K0065K000
Net income attributable to common stockholders 52.74%-758K54.49%-441K24.40%-3.76M74.74%-469K31.97%-717K-59.29%-1.6M8.15%-969K-104.52%-4.97M-264.83%-1.86M-1,966.67%-1.05M
Basic earnings per share 66.67%-0.0150.00%-0.0153.33%-0.07066.67%-0.0125.00%-0.0360.00%-0.0216.67%-0.150.00%-0.04-689.27%-0.03
Diluted earnings per share 66.67%-0.0150.00%-0.0153.33%-0.07066.67%-0.0125.00%-0.0360.00%-0.0216.67%-0.150.00%-0.04-689.27%-0.03
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --------------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data